Wednesday, May 07, 2025 3:40:57 PM
FeMike,
Hey we are all frustrated with how long this is taking but we both were looking at manufacturing being key more than two years ago. You basically said you hoped we would not be stuck with that burden but look at where we are at. Could it really have been anything else? By the way, insiders and friends may be able to work the best deals with the least risk but the low price is there for all investors to take advantage of. You were spacing your buys out by about a $.05 as I recall so you should have been able to get some at $.20 and I don’t think that opportunity makes us insiders or close friends. Granted we don’t get attached warrants but when validation finally comes anyone buying down at this level is not going to be complaining about anything other than wishing they had bought more. This is especially true if they were buying to hold and support NWBO efforts to get this platform to patients while also keeping shares out of the hands of those desiring to derail that effort; ). Best wishes.
Hey we are all frustrated with how long this is taking but we both were looking at manufacturing being key more than two years ago. You basically said you hoped we would not be stuck with that burden but look at where we are at. Could it really have been anything else? By the way, insiders and friends may be able to work the best deals with the least risk but the low price is there for all investors to take advantage of. You were spacing your buys out by about a $.05 as I recall so you should have been able to get some at $.20 and I don’t think that opportunity makes us insiders or close friends. Granted we don’t get attached warrants but when validation finally comes anyone buying down at this level is not going to be complaining about anything other than wishing they had bought more. This is especially true if they were buying to hold and support NWBO efforts to get this platform to patients while also keeping shares out of the hands of those desiring to derail that effort; ). Best wishes.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
